7 Recruiting Recurrent Mantle Cell Lymphoma Phase 2 Clinical Trials
Active phase 2 studies for recurrent mantle cell lymphoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Recurrent Mantle Cell Lymphoma studiesPhase 2 Studies for Recurrent Mantle Cell Lymphoma
🔵 Active, Not Recruiting Phase1 / Phase2
Copanlisib and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Ultra Low Dose Radiation Delivered Before or After Chemotherapy-Free Targeted Therapy in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase1 / Phase2
Golcadomide in Combination With Rituximab for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase2
Nemtabrutinib With CAR T Therapy in Relapsed/Refractory Mantle Cell Lymphoma
📍 Vanderbilt University/Ingram Cancer Center — Nashville, Tennessee
View Study & Checklist ➔ 🟢 Recruiting Phase2
Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase2
Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
📍 Mayo Clinic in Rochester — Rochester, Minnesota
View Study & Checklist ➔ 🟢 Recruiting Phase2
Modified Immune Cells (CD19 CAR T Cells) and Acalabrutinib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔